Bioventus Financial Overview
Bioventus's market cap is currently $617.41M. The company's EPS TTM is $0.15; its P/E ratio is 66.43; Bioventus is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $0.20. See an overview of income statement, balance sheet, and cash flow financials.
